The study, published online this month by Breast Cancer Research and Treatment found that levels GRB7 or growth factor receptor bound protein seven key are on their own as a marker for aggressive breast cancer. Previously , it was assumed that patients whose breast cancer tumors tested high HER-2 positive, the protein of human epidermal growth factor receptor-2, an aggressive form of the disease than patients whose tumors do not have elevated tend this protein. However, OHSU Knight Cancer Institute researchers found that the protein is driving this aggressive form of the disease GRB7 instead HER-2 is on its own levitra price . ‘Our work shows GRB7 protein levels are an important and independent factor in determining the prognosis of breast cancer,’said OHSU Knight Cancer Institute member Shiuh – Wen Luoh, Assistant Professor of Medicine in the Division of Hematology and Oncology, medical Oncology, Director of the Comprehensive Breast Cancer Clinic and senior author of the paper.
Study found that the genes GRB7 an aggressive form of breast cancer DrivesOregon Health & Science University Knight Cancer Institute researchers found that the gene GRB7 driving an aggressive form of breast cancer and acts independently of the HER – 2 gene, known to be a stimulator of breast cancer growth. Isolation of the role of this gene could ultimately help enable fine tuning of the treatment of patients and doctors to make a more accurate prognosis.
The Systolic or Heart Failure Treatment with the If Inhibitor Ivabradine Trial to investigate whether reduction in heart rate by using ivabradine reduce cardiovascular death of and hospital stay worsening heart failure for patients with a chronic heart failure, beats per minute. Dysfunction and a high heart rate , that. For a median of 22.9 months follow-up Oder placebo addition to the default congestive heart failure treatment treatment, 6505 patients from 37 countries been a random ivabradine is associated.
Notes? 6 percent of the general population be to fuel poverty, patients in need, and Climate Change fuel poverty Statistic, 19 percent of cancer patients undergoing treatment of the last year have in the fuel poverty, Macmillan Cancer Support online questionnaire from 974 people living with cancer, May 2009.